| Similar Articles |
|---|
 |
The Motley Fool
July 24, 2007
Brian Lawler |
MGI Flies Shares of MGI Pharma rise after positive second-quarter results and a bright outlook for the coming months.   |
The Motley Fool
December 11, 2007
Brian Lawler |
The MGI Deal Makes Sense MGI Pharma announces it is being acquired by Japanese pharma giant Eisai for $3.9 billion. |
The Motley Fool
October 23, 2006
Brian Lawler |
MGI's Anonymous Growth If there's a value stock in the pharma world, this may be it. |
The Motley Fool
September 3, 2004
Charly Travers |
MGI Pharma's Shopping Spree The company is filling out its drug pipeline with acquisitions. |
The Motley Fool
November 30, 2007
Brian Lawler |
MGI's Turn for "Strategic Alternatives" MGI Pharma is the latest in a growing list of drugmakers looking for someone to acquire them. The company may be a relatively more attractive takeover target than other drugmakers, because it's two lead drugs are unpartnered in the U.S. |
BusinessWeek
August 9, 2004
Gene G. Marcial |
MGI Pharma Has Just What Patients Need Its first major drug, an injection to prevent chemotherapy-induced nausea and vomiting, is on fire in a $1.5 billion market. And turning MGI into a moneymaker. |
BusinessWeek
September 4, 2006
Gene G. Marcial |
A Super Outlook For SuperGen Biotechs have not fared well in this fickle market. |
The Motley Fool
October 16, 2006
Brian Lawler |
MGI Drug Approval Falters The FDA gives the thumbs-down to Saforis. However, investors should take notice of this well-run pharmaceutical. |
BusinessWeek
March 12, 2007
Gene G. Marcial |
SuperGen Is Looking Healthier Biotechs are gaining traction this year as fund managers discover many with viable products that are still underpriced. |
The Motley Fool
July 3, 2008
Brian Lawler |
Celgene Savors the Schadenfreude Bad news for a rival is a bonanza for drugmaker Celgene. |
Pharmaceutical Executive
November 1, 2006
Marcee Nelson |
Direct to Consumer: Emotional Connection By reaching out to women, pharma companies can build more meaningful brands. |
